Biotech · Private company · Newark, CA, US
Medfree, Inc.
Track this companyFree. Adds Medfree, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Novel Self-closing 12F Mitral Valve Repair System to Percutaneously Treat Moderate to Severe Regurgitation Using Transcatheter Edge-to-Edge Repair (TEER) Technique Via Femoral Vein Access.Fiscal year 2025 · $219.3KNIH RePORTER 5SB1HL174244-02 · fetched Nov 12, 2026
- Novel Self-closing 12F Mitral Valve Repair System to Percutaneously Treat Moderate to Severe Regurgitation Using Transcatheter Edge-to-Edge Repair (TEER) Technique Via Femoral Vein Access.Fiscal year 2024 · $275.5KNIH RePORTER 1SB1HL174244-01 · fetched Nov 12, 2026